Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

William K. Mcvicar

President and CEO
Biotechnology
Flex Pharma
United States of America

Biography

William K. McVicar, Ph.D., was appointed CEO in July 2017 after joining Flex Pharma in April 2017 as President of Research & Development. Dr. McVicar brings to Flex Pharma approximately 30 years of clinical development experience. Prior to joining Flex Pharma, Dr. McVicar served as Executive Vice President of Pharmaceutical Development, Chief Scientific Officer, and President during his tenure at Inotek. As Vice President of Development Operations at Sepracor, he oversaw the development, FDA review, and approval of multiple NDAs and SNDAs, including BROVANA®, XOPENEX MDI®, and XOPENEX’s pediatric approval, which were each approved in a single 10-month review cycle. Prior to Sepracor, Dr. McVicar held various positions of increasing responsibility at Sandoz, Novartis and Rhone Poulenc Rorer. 

Research Interest

Neuro Muscular Disorders, including Muscle Cramps 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
View more
Relevant Topics